G

Generation Bio Co
D

GBIO

0.60660
USD
-0.01
(-1.49%)
Market Closed
Volume
16,050
EPS
-1
Div Yield
-
P/E
-0
Market Cap
40,516,526
OverviewSignalsIdeasNews
Related Instruments
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    B
    BEAM
    -2.705
    (-8.16%)
    30.445 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    IDXX
    IDXX
    -0.33
    (-0.07%)
    452.66 USD
    N
    NTLA
    -0.075
    (-0.61%)
    12.180 USD
    R
    RARE
    -1.920
    (-4.31%)
    42.590 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    More
News

Title: Generation Bio Co

Sector: Healthcare
Industry: Biotechnology
Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.